QIU, Yao-ling,CAO, Hui,GAO, Xuri,KASS, Jordan,LI, Wei,PENG, Xiaowen,SUH, Byung-chul,OR, Yat Sun
申请号：
AU2018326474
公开号：
AU2018326474A1
申请日:
2018.08.28
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
